Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Prognostic value of the micronucleus assay for clinical endpoints in neoadjuvant radiochemotherapy for rectal cancer

Fig. 2

Micronuclei (MN) and nucleoplasmatic bridges (NPB) counted in binucleated lymphocytes (BNL) of rectal cancer patients. The yields after 50.4 Gy of radiochemotherapy (RCT) plotted against the individual planning target volume size. The RCT-induced cytogenetic damage as measured by MN (p = 0.002) (a) and NPB (p = 0.001) (b) increased significantly with the PTV size

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us